SPOTLIGHT -
Dr. Ahmed on the Need for Multidisciplinary Care in HER2+ Breast Leptomeningeal Disease
Kamran A. Ahmed, MD, discusses the need for multidisciplinary care in patients with HER2-positive breast cancer and leptomeningeal disease.
Read More
Dr. Ahmed on the Impact of Neratinib on CNS Metastases in HER2+ Breast Cancer
Kamran A. Ahmed, MD, discusses the impact of neratinib on patients with central nervous system metastases and HER2-positive breast cancer.
Dr. Ahmed on the Role of Multidisciplinary Care in Breast Cancer Brain Metastases
Kamran A. Ahmed, MD, discusses the role of multidisciplinary care in breast cancer–related brain metastases.
Dr. Ahmed on Remaining Questions With Tucatinib in Breast Cancer Brain Metastases
Kamran A. Ahmed, MD, discusses remaining questions with the use of tucatinib in breast cancer–related brain metastases.
Dr. Ahmed on Key Strategies for Managing Breast Cancer Brain Metastases
Kamran A. Ahmed, MD, discusses key strategies to manage patients with breast cancer and brain metastases.
Tusamitamab Ravtansine Plus Pembrolizumab With or Without Chemo Elicits Responses in CEACAM5+ NSCLC
Cemiplimab Monotherapy Induces Durable OS, PFS Benefits in PD-L1+ NSCLC With Brain Metastases
Four Cycles of Chemotherapy Plus Tremelimumab and Durvalumab Demonstrate Optimized Outcomes in Metastatic NSCLC
Taletrectinib Elicits Durable Responses in TKI-Naïve and Crizotinib-Pretreated ROS1+ NSCLC
